H
Harvey L. Levy
Researcher at Boston Children's Hospital
Publications - 327
Citations - 11629
Harvey L. Levy is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Newborn screening & Pregnancy. The author has an hindex of 57, co-authored 319 publications receiving 10744 citations. Previous affiliations of Harvey L. Levy include Harvard University & Rhode Island Hospital.
Papers
More filters
Journal ArticleDOI
Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary
Michael S. Watson,Marie Y. Mann,Michele A. Lloyd-Puryear,Piero Rinaldo,R. Rodney Howell,José F. Cordero,E. Steven Edwards,Jennifer L. Howse,Tricia Mullaley,Peter C. van Dyck,William Becker,Coleen A. Boyle,George C. Cunningham,Michael R. DeBaun,Stephen M. Downs,Edward B. Goldman,Stephen I. Goodman,Fernando Guerra,W. Harry Hannon,James W. Hanson,Cecilia Larson,Scott D. McLean,Gurvaneet Randhawa,Derek Robertson,Mark A. Rothstein,Robert D. Steiner,Sonia M. Suter,Bradford L. Therrell,Thomas F. Tonniges,Wanda Yazzie,Donald B. Bailey,Celia I. Kaye,Alex R. Kemper,Kenneth A. Pass,Jennifer M. Puck,Franklin Desposito,Gary Hoffman,Kathy Stagni,Arnold W. Strauss,Tracy L. Trotter,Anne M. Willey,Harvey L. Levy,James R. Eckman,Fred Lorey,Deborah Marsden,Julie Miller,Danielle Laraque,Kelly R. Leight,Barbara P. Yawn,Edward B. Goldman,Beverly Dozier,Lynn D. Fleisher +51 more
TL;DR: The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process of standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screenings programs.
Journal ArticleDOI
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.
Roger R. Lenke,Harvey L. Levy +1 more
TL;DR: The objective was to determine the effect of maternal PKU and hyperphenylalaninemia on the offspring of suc...
Journal ArticleDOI
Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress
Susan E. Waisbren,Simone Albers,Steve Amato,Mary G. Ampola,Thomas G. Brewster,Laurie A. Demmer,Roger B. Eaton,Robert M. Greenstein,Mark S. Korson,Cecilia A. Larson,Deborah Marsden,Michael E. Msall,Edwin W. Naylor,Siegfried M. Pueschel,Margretta R. Seashore,Vivian E. Shih,Harvey L. Levy +16 more
TL;DR: To compare newborn identification by expanded screening with clinical identification of biochemical genetic disorders and to assess the impact on families of a false-positive screening result compared with a normal result in the expanded newborn screening program.
Journal ArticleDOI
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
Harvey L. Levy,Andrzej Milanowski,Anupam Chakrapani,Maureen Cleary,Philip Lee,Friedrich K. Trefz,Chester B. Whitley,François Feillet,Annette Feigenbaum,Judith Bebchuk,Heidi Christ-Schmidt,Alex Dorenbaum +11 more
TL;DR: In some patients with phenylketonuria who are responsive to BH4, sapropterin treatment to reduce blood phenylalanine could be used as an adjunct to a restrictive low-phenylAlanine diet, and might even replace the diet in some instances.
Journal ArticleDOI
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
Susan E. Waisbren,Kay Noel,Kyle Fahrbach,Catherine Cella,Diana Frame,Alex Dorenbaum,Harvey L. Levy +6 more
TL;DR: A significant correlation between blood Phe level and IQ in patients with PKU is confirmed, and the use of Phe as a predictive biomarker for IQ in clinical trials is supported.